Compare FAST & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FAST | BDX |
|---|---|---|
| Founded | 1967 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.2B | 54.6B |
| IPO Year | 1995 | 1999 |
| Metric | FAST | BDX |
|---|---|---|
| Price | $55.41 | $217.32 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 18 | 16 |
| Target Price | $51.15 | ★ $226.14 |
| AVG Volume (30 Days) | ★ 7.1M | 1.8M |
| Earning Date | 10-14-2026 | 11-05-2026 |
| Dividend Yield | 1.87% | ★ 1.97% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.98 | ★ 1.59 |
| Revenue | $8,200,500,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $13.80 | $1.74 |
| Revenue Next Year | $9.70 | $4.24 |
| P/E Ratio | ★ $56.70 | $135.59 |
| Revenue Growth | ★ 8.67 | 8.24 |
| 52 Week Low | $38.97 | $140.11 |
| 52 Week High | $56.27 | $216.85 |
| Indicator | FAST | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 68.52 | 75.52 |
| Support Level | $43.71 | $175.60 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.22 | 4.53 |
| MACD | 0.28 | 1.11 |
| Stochastic Oscillator | 83.67 | 92.19 |
Fastenal began as an industrial retailer, expanding its product portfolio from nuts and bolts to cutting tools, safety equipment, and janitorial supplies. It transitioned into a distributor by building out a dense network of branches close to its business customers. Once a customer becomes large enough, Fastenal installs vending machines and its own personnel on-site. Today, these on-site locations exceed Fastenal's branch count and remain the firm's main focus for expansion. Fastenal acts as a one-stop outsourcing partner for its industrial customers, offering value-added services along with a wide breadth of maintenance, repair, and operations supplies.
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.